Title of article
Cisplatin and gemcitabine in the management of metastatic penile cancer
Author/Authors
Power، نويسنده , , Derek G. and Galvin، نويسنده , , David J. and Cuffe، نويسنده , , Sinead and McVey، نويسنده , , Gerald P. and Mulholland، نويسنده , , Paul J. and Farrelly، نويسنده , , Cormac and Delaney، نويسنده , , David W. and OʹByrne، نويسنده , , Kenneth J.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2009
Pages
4
From page
187
To page
190
Abstract
Penile cancer is rare and receives little public attention. There are few treatment options for advanced disease. The most active regimen to date is a combination of bleomycin, methotrexate, and cisplatin. However the treatment-related mortality is 11% and hence this combination has not been adapted as a standard of care. We report two cases of advanced penile cancer where a sustained palliative response was observed with combination chemotherapy using cisplatin and gemcitabine. Our experience demonstrates that this is a well tolerated regimen active in this setting.
Keywords
penile , Metastatic , radiotherapy , cancer , chemotherapy
Journal title
Urologic Oncology
Serial Year
2009
Journal title
Urologic Oncology
Record number
1889211
Link To Document